Actively Recruiting
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Led by China-Japan Friendship Hospital · Updated on 2025-08-03
800
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
CONDITIONS
Official Title
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- BMI >27.5 kg/m2
- Diagnosis of type 2 diabetes mellitus
- Scheduled to undergo bariatric surgery
You will not qualify if you...
- No abdominal CT scan available
- Did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yuntao Nie
Beijing, China, 100029
Actively Recruiting
Research Team
Y
Yuntao Nie, M.D.
CONTACT
H
Hua Meng, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here